Clinical Trial Update: A Study of Ciclesonide Nasal Spray in Patients 18 Years and Older With Seasonal Allergic Rhinitis (BY9010/M1-413) [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update reporting completion of a study evaluating ciclesonide nasal spray in adults with seasonal allergic rhinitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Seasonal Allergic Rhinitis

Drugs mentioned

• Ciclesonide nasal spray (ciclesonide)

Snippet

Sponsor: AstraZeneca | Conditions: Rhinitis, Allergic, Seasonal, Hay Fever | Phase 3 | Status: COMPLETED